Potassium canrenoate: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
'''Potassium canrenoate''' | {{Short description|A potassium-sparing diuretic used in medicine}} | ||
{{Drugbox | |||
| verifiedfields = changed | |||
| verifiedrevid = 477002123 | |||
| image = Potassium_canrenoate.svg | |||
| image2 = | |||
| width = 200px | |||
| alt = | |||
}} | |||
'''Potassium canrenoate''' is a [[potassium-sparing diuretic]] that is used in the treatment of conditions such as [[heart failure]], [[hypertension]], and [[edema]]. It is a prodrug of [[canrenone]], which acts as an [[aldosterone antagonist]]. | |||
==Pharmacology== | ==Pharmacology== | ||
Potassium canrenoate | Potassium canrenoate works by inhibiting the effects of [[aldosterone]], a hormone that promotes the retention of [[sodium]] and [[water]] in the body. By blocking aldosterone, potassium canrenoate helps to increase the excretion of sodium and water while retaining potassium, thus acting as a diuretic. | ||
==Mechanism of Action== | |||
[[File:Potassium_canrenoate.svg|thumb|right|Chemical structure of potassium canrenoate]] | |||
Potassium canrenoate is converted in the body to its active form, canrenone. Canrenone competes with aldosterone for receptor sites in the [[distal convoluted tubule]] and [[collecting duct]] of the [[nephron]], reducing sodium reabsorption and increasing potassium retention. | |||
== | ==Clinical Uses== | ||
Potassium canrenoate is used in the | Potassium canrenoate is primarily used in the management of conditions where fluid retention is a problem, such as: | ||
* [[Congestive heart failure]] | |||
* [[Cirrhosis]] of the liver with ascites | |||
* [[Nephrotic syndrome]] | |||
* [[Hypertension]] | |||
==Side Effects== | |||
Common side effects of potassium canrenoate include: | |||
* [[Hyperkalemia]] (elevated potassium levels) | |||
* [[Hyponatremia]] (low sodium levels) | |||
* [[Gynecomastia]] | |||
* [[Gastrointestinal disturbances]] | |||
== | ==Contraindications== | ||
Potassium canrenoate should not be used in patients with: | |||
* [[Hyperkalemia]] | |||
* Severe [[renal impairment]] | |||
* [[Addison's disease]] | |||
== | ==Related pages== | ||
* [[ | * [[Diuretics]] | ||
* [[ | * [[Aldosterone antagonist]] | ||
* [[ | * [[Heart failure]] | ||
* [[Hypertension]] | |||
[[Category:Diuretics]] | [[Category:Diuretics]] | ||
[[Category:Potassium-sparing diuretics]] | [[Category:Potassium-sparing diuretics]] | ||
[[Category:Aldosterone antagonists]] | |||
Latest revision as of 05:20, 16 February 2025
A potassium-sparing diuretic used in medicine
Potassium canrenoate is a potassium-sparing diuretic that is used in the treatment of conditions such as heart failure, hypertension, and edema. It is a prodrug of canrenone, which acts as an aldosterone antagonist.
Pharmacology[edit]
Potassium canrenoate works by inhibiting the effects of aldosterone, a hormone that promotes the retention of sodium and water in the body. By blocking aldosterone, potassium canrenoate helps to increase the excretion of sodium and water while retaining potassium, thus acting as a diuretic.
Mechanism of Action[edit]
Potassium canrenoate is converted in the body to its active form, canrenone. Canrenone competes with aldosterone for receptor sites in the distal convoluted tubule and collecting duct of the nephron, reducing sodium reabsorption and increasing potassium retention.
Clinical Uses[edit]
Potassium canrenoate is primarily used in the management of conditions where fluid retention is a problem, such as:
- Congestive heart failure
- Cirrhosis of the liver with ascites
- Nephrotic syndrome
- Hypertension
Side Effects[edit]
Common side effects of potassium canrenoate include:
- Hyperkalemia (elevated potassium levels)
- Hyponatremia (low sodium levels)
- Gynecomastia
- Gastrointestinal disturbances
Contraindications[edit]
Potassium canrenoate should not be used in patients with: